文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > Mattson review-alzheimer's disease老年痴呆症
侵权投诉

Mattson review-alzheimer's disease老年痴呆症

Alzheimer's disease 老年痴呆症

reviewarticle

modi cationsofdietandlifestyleisofconsiderableinterest,andsuggeststhepotentialforreducingtheincidenceofADbypreventativestrategiessimilartothosethatreducetheriskofcardiovasculardisease.

Targetedtherapeutics

8.9.10.11.12.

Tanzi,R.E.&Bertram,L.NewfrontiersinAlzheimer’sdiseasegenetics.Neuron32,181–184(2001).Mayeux,R.Epidemiologyofneurodegeneration.Annu.Rev.Neurosci.26,81–104(2003).

Mattson,M.P.Gene-dietinteractionsinbrainagingandneurodegenerativedisorders.Ann.Intern.Med.139,441–444(2003).

Young,D.etal.Environmentalenrichmentinhibitsspontaneousapoptosis,preventsseizuresandisneuroprotective.NatureMed.5,448–453(1999).

Lee,J.,Duan,W.&Mattson,M.P.Evidencethatbrain-derivedneurotrophicfactorisrequiredforbasalneurogenesisandmediates,inpart,theenhancementofneurogenesisbydietaryrestrictioninthehippocampusofadultmice.J.Neurochem.82,1367–1375(2002).

Cotman,C.W.&Berchtold,N.C.Exercise:abehavioralinterventiontoenhancebrainhealthandplasticity.TrendsNeurosci.25,295–301(2002).

Bush,A.I.,Masters,C.L.&Tanzi,R.E.Copper,beta-amyloid,andAlzheimer’sdisease:tappingasensitiveconnection.Proc.NatlAcad.Sci.USA100,11193–11194(2003).

Haass,C.etal.TheSwedishmutationcausesearly-onsetAlzheimer’sdiseasebybeta-secretasecleavagewithinthesecretorypathway.NatureMed.1,1291–1296(1995).

Scheuner,D.etal.Secretedamyloidbeta-proteinsimilartothatinsenileplaquesofAlzheimer’sdiseaseisincreasedinvivobythepresenilin1and2APPmutationslinkedtofamilialAlzheimer’sdisease.NatureMed.2,864–870(1996).

Mattson,M.P.Cellularactionsofbeta-amyloidprecursorproteinanditssolubleand brillogenicderivatives.Physiol.Rev.77,1081–1132(1997).

Morgan,D.etal.AbetapeptidevaccinationpreventsmemorylossinananimalmodelofAlzheimer’sdisease.Nature408,982–985(2000).

Butter eld,D.A.etal.EvidenceofoxidativedamageinAlzheimer’sdiseasebrain:centralroleforamyloidbeta-peptide.TrendsMol.Med.7,548–554(2001).

Smith,M.A.etal.IronaccumulationinAlzheimerdiseaseisasourceofredox-generatedfreeradicals.Proc.NatlAcad.Sci.USA94,9866–9868(1997).

Blass,J.P.Brainmetabolismandbraindisease:ismetabolicde ciencytheproximatecauseofAlzheimerdementia?J.Neurosci.Res.66,851–856(2001).

Dodart,J.C.etal.Earlyregionalcerebralglucosehypometabolismintransgenicmice

overexpressingtheV717Fbeta-amyloidprecursorprotein.Neurosci.Lett.277,49–52(1999).Buchner,M.,Huber,R.,Sturchler-Pierrat,C.,Staufenbiel,M.&Riepe,M.W.ImpairedhypoxictoleranceandalteredproteinbindingofNADHinpresymptomaticAPP23transgenicmice.Neuroscience114,285–289(2002).

Watson,G.S.&Craft,S.TheroleofinsulinresistanceinthepathogenesisofAlzheimer’sdisease:implicationsfortreatment.CNSDrugs17,27–45(2003).

Gabuzda,D.,Busciglio,J.,Chen,L.B.,Matsudaira,P.&Yankner,B.A.Inhibitionofenergymetabolismalterstheprocessingofamyloidprecursorproteinandinducesapotentiallyamyloidogenicderivative.J.Biol.Chem.269,13623–13628(1994).

Saito,K.etal.Widespreadactivationofcalcium-activatedneutralproteinase(calpain)inthebraininAlzheimerdisease:apotentialmolecularbasisforneuronaldegeneration.Proc.NatlAcad.Sci.USA90,2628–2632(1993).

Mattson,M.P.&Chan,S.L.NeuronalandglialcalciumsignalinginAlzheimer’sdisease.CellCalcium34,385–397(2003).

Le,Y.etal.Amyloid(beta)42activatesaG-protein-coupledchemoattractantreceptor,FPR-like-1.J.Neurosci.21,RC123(2001).

LaFerla,F.M.CalciumdyshomeostasisandintracellularsignalinginAlzheimer’sdisease.NatureRev.Neurosci.3,862–872(2002).

Yang,Y.&Cook,D.G.Presenilin-1de ciencyimpairsglutamate-evokedintracellularcalciumresponsesinneurons.Neuroscience124,501–506(2004).

Eckert,A.etal.Alzheimer’sdisease-likealterationsinperipheralcellsfrompresenilin-1transgenicmice.Neurobiol.Dis.8,331–342(2001).

Puglielli,L.,Tanzi,R.E.&Kovacs,D.M.Alzheimer’sdisease:thecholesterolconnection.NatureNeurosci.6,345–351(2003).

Wolozin,B.etal.DecreasedprevalenceofAlzheimerdiseaseassociatedwith3-hydroxy-3-methyglutarylcoenzymeAreductaseinhibitors.Arch.Neurol.57,1439–1443(2000).

Fassbender,K.etal.SimvastatinstronglyreduceslevelsofAlzheimer’sdiseasebeta-amyloidpeptidesAbeta42andAbeta40invitroandinvivo.Proc.NatlAcad.Sci.USA98,5856–5861(2001).Kalmijn,S.Fattyacidintakeandtheriskofdementiaandcognitivedecline:areviewofclinicalandepidemiologicalstudies.J.Nutr.HealthAging4,202–207(2000).

Ehehalt,R.etal.AmyloidogenicprocessingoftheAlzheimerbeta-amyloidprecursorproteindependsonlipidrafts.J.CellBiol.160,113–123(2003).

Cutler,R.G.etal.InvolvmentofperturbedceramideandcholesterolmetabolisminbrainagingandAlzheimer’sdisease.Proc.NatlAcad.Sci.USA101,2070–2075(2004).

Farlow,M.AclinicaloverviewofcholinesteraseinhibitorsinAlzheimer’sdisease.Int.Psychogeriatr.14,93–126(2002).

West,M.J.etal.DifferencesinthepatternofhippocampalneuronallossinnormalageingandAlzheimer’sdisease.Lancet344,769–772(1994).

Gomez-Isla,T.etal.Neuronallosscorrelateswithbutexceedsneuro brillarytanglesinAlzheimer’sdisease.Ann.Neurol.41,17–24(1997).

Lustbader,J.W.etal.ABADdirectlylinksAbetatomitochondrialtoxicityinAlzheimer’sdisease.Science304,448–452(2004).

McGeer,P.L.&McGeer,E.G.Localneuroin ammationandtheprogressionofAlzheimer’sdisease.J.Neurovirol.8,529–538(2002).

Xu,J.etal.Amyloid-betapeptidesarecytotoxictooligodendrocytes.J.Neurosci.21,RC118(2001).

Schenk,D.etal.Immunizationwithamyloid-betaattenuatesAlzheimer-disease-likepathologyinthePDAPPmouse.Nature400,173–177(1999).

Bard,F.etal.Peripherallyadministeredantibodiesagainstamyloidbeta-peptideenterthecentralnervoussystemandreducepathologyinamousemodelofAlzheimerdisease.NatureMed.6,916–919(2000).

Jantzen,P.T.etal.Microglialactivationandbeta-amyloiddepositreductioncausedbyanitricoxide-releasingnonsteroidalanti-in ammatorydruginamyloidprecursorproteinpluspresenilin-1transgenicmice.J.Neurosci.22,2246–2254(2002).

DeKosky,S.T.&Scheff,S.W.SynapselossinfrontalcortexbiopsiesinAlzheimer’sdisease:correlationwithcognitiveseverity.Ann.Neurol.27,457–464(1990).

Drugsareindevelopmentthattargetspeci csitesintheneuro-degenerativecascade.BecausetheproductionofneurotoxicformsofAbfromAPPappearstobeapivotaleventinADpathogenesis,thereisintenseinterestindevelopingdrugsthatblocktheb-org-secretaseenzymes.Speci cg-secretaseinhibitorsthatdecreaseAbproductionhavebeenproduced54,buttheiruseinhumansmaybecompromisedbysideeffectsresultingfromblockadeofg-secretasecleavageofNotchandotherproteinsubstrates.BACEinhibitors55mayprovebene cialinreducingAbproductionwithoutmajorsideeffects,becauseBACE-de cientmicehavereducedAbproductionanddonotexhibitanyovertabnormalphenotypes56.Anotherapproachtoreducingamyloidaccumulationinthebrainisagentsthatchelatecopperandiron14,57;suchchelatorswouldalsobeexpectedtoreduceoxidativestressinneurons.TheemerginglinkbetweencholesterollevelsandADhasledtotrialsofcholesterol-loweringstatinsinADpatients(doc.guandang.net).

OnepromisingapproachforpreventingandtreatingADisbaseduponstimulatingtheimmunesystemtoremoveAbfromthebrain.TheinitialreportsthatimmunizationwithhumanAb42(ref.58)orpassiveimmunizationwithAbantibodies59resultintheclearanceofAbplaquesfromthebrainsofAPPmutanttransgenicmicewerefollowedbyreportsthatsuchimmunizationapproachescanalsoamelioratememoryde citsinthemice18,60.TheresultsofaninitialclinicaltrialsuggestthatAbimmunizationmaybeaneffectivetreatmentforAD,althoughadversereactionsoccurredinsomepatientsandre nementoftheimmunizationmethodswillberequired61.Inaddition,therateofcognitivedeclineintheADgroupthatreceivedthevaccinebutdidnotrespondbyplaqueclearancewasmuchgreaterthanistypicallyseeninADpatients.Therefore,althoughthevaccineresponderswerecognitivelybetterthanthenon-responders,theirrateofcognitivedeclinewassimilartothattypicalforpatientswithsporadicAD.Itshouldalsobenotedthattherehavebeenmanyfailuresoftrialsinhumanpatientsoftreat-mentsthatworkedwellinanimalmodelsofotherneurodegenerativedisorders,includingParkinson’sdiseaseandstroke.Nevertheless,aneffectivevaccinewouldhaveamajorimpactonthedisease,andiscurrentlyoneofthemostexcitingareasofADresearch.

Othertherapeuticapproachesbeingtestedincludeanti-in am-matoryagentssuchasCOX-2inhibitorsandaspirin62,andsteroidsthatdeclineduringnormalageingsuchasoestrogenandtesto-sterone63.Drugsthattargetspeci csitesinneurodegenerativecascadeshave,todate,onlybeenemployedincellcultureandanimalmodelsofAD,andtheirpotentialintheclinicremainsunclear.Finally,theabilitytoidentifyindividualsatriskforAD,basedupongenetic(ApoE4genotype,forexample)orenvironmental(overweightsedentarylifestyle)factors,willallowtheapplicationofmoreaggressiveinterventionsinthoseindividuals.A

doi:10.1038/nature02621.

1.2.3.4.5.6.7.

Dickson,D.W.NeuropathologicaldiagnosisofAlzheimer’sdisease:aperspectivefromlongitudinalclinicopathologicalstudies.Neurobiol.Aging18,S21–S26(1997).

Braak,H.&Braak,E.EvolutionofneuronalchangesinthecourseofAlzheimer’sdisease.J.NeuralTransm.Suppl.53,127–140(1998).

Selkoe,D.J.&Schenk,D.Alzheimer’sdisease:molecularunderstandingpredictsamyloid-basedtherapeutics.Annu.Rev.Pharmacol.Toxicol.43,545–584(2003).

Hardy,J.Amyloid,thepresenilinsandAlzheimer’sdisease.TrendsNeurosci.20,154–159(1997).Sherrington,R.etal.Cloningofagenebearingmissensemutationsinearly-onsetfamilialAlzheimer’sdisease.Nature375,754–760(1995).

Levy-Lahad,E.etal.Candidategeneforthechromosome1familialAlzheimer’sdiseaselocus.Science269,973–977(1995).

Roses,A.D.Amodelforsusceptibilitypolymorphismsforcomplexdiseases:apolipoproteinEandAlzheimerdisease.Neurogenetics1,3–11(1997).

13.14.15.16.

17.18.19.20.21.22.23.

24.25.

26.

27.28.29.30.31.32.33.34.35.36.37.38.39.40.41.42.43.44.45.

46.

47.

638

©2004Nature PublishingGroup

NATURE|VOL430|5AUGUST2004|doc.guandang.net

上一页第8页

你可能喜欢

热门文档

相关文档

  • 阿尔茨海默病Alzheimer`s disease

    Mattson review-alzheim... 9页 1下载券 Iron-Export Ferroxidas... 11页 ...网址(参阅以上附加链接)阿尔茨海默氏病国际 (Alzheimer's Disease International)...

  • Alzheimer' Disease (AD) Regimen 老年痴呆症 May 2014

    Regimen Summary of Peptide Medicines for Alzheimer’ Disease (AD) Treatment ---Summarized peptide regimen for in vivo AD study Animal Study Model 3xTg-AD...

  • Alzheimer's disease is a synaptic failure

    ALZHEIMER’S DISEASE 41页 1下载券 喜欢此文档的还喜欢 2010-Alzheimer's-... Mattson review-alzheim... 9页 1下载券 Alzheimer’s disease s... 12页...

  • 2010-Alzheimer's-disease-facts-and-figures

    Therapy_of_Alzheimer's... 19页 免费 Mattson review-alzheim... 9页 1...(2010) 158–194 Alzheimer’s Association Report 2010 Alzheimer’s disease ...

  • 健康讲座--老年痴呆

    健康讲座--老年痴呆_医药卫生_专业资料。老年痴呆症,又称阿尔茨海默病(Alzheimer'sdisease,AD)是发生在老年期及老年前期的一种原发性退行性脑病,指的是一种持续...

  • 老年痴呆论文

    其中,阿尔茨海默病 (Alzheimer's disease,AD),是一种最常见的、主要的老年痴呆症 ,它是一种进行 性发展的致死性神经退行性疾病,临床表现为认知和记忆功能不断...

  • MCIscra Alzheimer's Disease ppt

    Alzheimer's Disease Summ... 14页 20财富值 Therapy_of_Alzheimer's_D....AT ALL LEVELS (Ashford, Mattson, Kumar, 1998; Teter, Ashford, 2002) ? ...

  • 视听说课件b3u1with alzheimer's you meet a lot of ne...

    ? ? ? ? Spelling (30s) 老年痴呆症 Alzheimer...The memory curve: review and try to use the ...Alzheimer’s disease: condition in which a ...

  • 老年疾病(部分)

    什么是老年痴呆所谓的老年痴呆症,又称阿尔茨海默病 (Alzheimer's disease,AD) 是发 生在老年期及老年前期的一种原发性退行性脑病, 指的是一种持续性高级神经功...

  • 银杏叶提取物

    1 病因病机 老年痴呆症主要包括阿尔茨海默病 (Alzheimer’ s disease , AD) 和血管性痴呆(Vascular Dementia,VD)、混合性痴呆、其他痴呆(外伤、帕金森)。AD 和 ...

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email